SVB WEALTH LLC - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
SVB WEALTH LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$125,000
-59.4%
30,550
-37.1%
0.01%
-61.5%
Q3 2016$308,000
+17.6%
48,5500.0%0.01%
+18.2%
Q2 2016$262,000
-35.5%
48,5500.0%0.01%
-35.3%
Q1 2016$406,000
+5.7%
48,5500.0%0.02%
+13.3%
Q4 2015$384,000
-34.0%
48,550
-29.0%
0.02%
-34.8%
Q3 2015$582,000
-31.1%
68,3650.0%0.02%
-17.9%
Q2 2015$845,000
+4.1%
68,3650.0%0.03%
+7.7%
Q1 2015$812,000
+5.0%
68,3650.0%0.03%
+4.0%
Q4 2014$773,00068,3650.02%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders